- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04148417
Clinical Study of the Solo+ Tympanostomy Tube Device
January 23, 2024 updated by: AventaMed DAC
The objective of this study is to evaluate the safety and performance of the Solo+ Tympanostomy Tube Device for the placement of tympanostomy tubes (grommets) in paediatric patients undergoing a tympanostomy procedure
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Detailed Description
The study will be a multi-site, prospective, treatment-only study of the Solo+ Tympanostomy Tube Device.
Patients will already have a scheduled tympanostomy procedure.
Study Type
Interventional
Enrollment (Estimated)
27
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
District of Columbia
-
Washington, District of Columbia, United States, 20010
- Children's National Medical Center
-
-
Wisconsin
-
Milwaukee, Wisconsin, United States, 53226
- Children's Hospital of Wisconsin
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
6 months to 15 years (Child)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Listed for bilateral tympanostomy tube insertion
Exclusion Criteria:
- Anatomy that precludes sufficient visualisation of both the left and right eardrum
- Narrow ear canals
- Anatomy that precludes safe access to both the left and right eardrum
- Membrane >25% sclerosis
- Congenital or craniofacial abnormalities
- No available baseline audiometry and tympanometry
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Solo+ Tympanostomy Tube Device
The Solo+ Tympanostomy Tube Device is a disposable surgical tool designed to deliver a tympanostomy tube (grommet) into the tympanic membrane of patients undergoing a tympanostomy tube placement procedure
|
The Solo+ Tympanostomy Tube Device is intended to deliver a tympanostomy tube through the tympanic membrane of a patient during a tympanostomy procedure
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Successful delivery of the tympanostomy tube by the Solo+ Tympanostomy Tube Device
Time Frame: Intra-operative
|
The number of ears in which the Solo Tympanostomy Tube Device tube is placed
|
Intra-operative
|
Rate of Adverse Events
Time Frame: 24 months
|
The number and type of Adverse Events
|
24 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Matija Daniel, Queen's Medical Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 9, 2021
Primary Completion (Estimated)
September 1, 2024
Study Completion (Estimated)
September 1, 2024
Study Registration Dates
First Submitted
October 30, 2019
First Submitted That Met QC Criteria
October 31, 2019
First Posted (Actual)
November 1, 2019
Study Record Updates
Last Update Posted (Estimated)
January 24, 2024
Last Update Submitted That Met QC Criteria
January 23, 2024
Last Verified
January 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CSP002
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Otitis Media
-
David Chi, MDRecruitingRecurrent Acute Otitis Media | Chronic Otitis Media With Effusion | Otitis Media in ChildrenUnited States
-
Bezmialem Vakif UniversityCompleted
-
Alcon ResearchCompletedOtitis Media With Effusion in Children | Otitis Media Recurrent
-
Tusker MedicalCompletedAOM - Acute Otitis Media | OME - Otitis Media With EffusionUnited States, Canada
-
Medical College of WisconsinNational Institutes of Health (NIH); National Institute on Deafness and Other... and other collaboratorsRecruitingOtitis Media | Otitis Media With Effusion | Otitis Media AcuteUnited States
-
Assistance Publique - Hôpitaux de ParisMinistry of Health, FranceCompletedChronic Serous Otitis Media, Simple or UnspecifiedFrance
-
Nationwide Children's HospitalWithdrawn
-
University Hospital, GhentWithdrawn
-
Yuinvent Innovations Ltd.UnknownOtitis Media With Effusion
-
AcclarentCompletedOtitis Media With EffusionUnited States
Clinical Trials on Solo+ Tympanostomy Tube Device
-
AventaMed DACRecruiting
-
AcclarentCompletedOtitis Media With Effusion | Acute Otitis MediaUnited States
-
Zealand University HospitalDanish Medical AssociationCompletedQuality of Life | Sleep | Otitis Media With Effusion in ChildrenDenmark
-
Eye & ENT Hospital of Fudan UniversityChildren's Hospital of Fudan University; Xinhua Hospital, Shanghai Jiao Tong...Not yet recruitingOtitis Media With Effusion in Children
-
AcclarentCompletedOtitis Media With EffusionUnited States
-
Preceptis Medical, Inc.Completed
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingOtitis Media With Effusion After Nasopharyngeal CarcinomaChina
-
AcclarentCompleted